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Toxic colitis is a well-described, life-threatening complication of inﬂammatory bowel disease (IBD). The
vast majority of reported cases have been in adults. Limited literature exists describing toxic colitis in
children with IBD. Virtually all reported pediatric cases have been in the setting of ulcerative colitis. We
present a case of a 10 year old girl with Crohn’s disease who was hospitalized because of advanced
perianal disease with multiple abscesses and ﬁstulae. During her stay, she developed acute toxic colitis
with perforation requiring emergent colectomy. It is essential that clinicians are aware that this cata-
strophic complication can occur rapidly in the pediatric IBD population to ensure timely and appropriate
management.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.Toxic colitis is a severe and life-threatening complication of
several inﬂammatory as well as infectious colitides [1]. Inﬂamma-
tory bowel disease (IBD) in children is generally associated with a
higher rate of severe exacerbations than in adults [2]. Surprisingly
little data exists on the incidence and diagnosis of toxic colitis in the
pediatric IBD population. Every case reported thus far has been in a
child with a primary diagnosis of ulcerative colitis (UC). We present
the ﬁrst case report of toxic colitis in a child with known Crohn’s
disease (CD).
1. Case report
A 10 year old girl with a 2.5 year history of CD presented with
abdominal pain, diarrhea, and increasing perineal pain associated
with fecal incontinence and purulent drainage per rectum. Her
disease had been limited to the colon, rectum and perineum. Recentates, 25 E. 69th Street, New
(D.A. Popowich).
Inc. Open access under CC BY-NC-SA licenscolonoscopy had shown stricturing, edema, friability, stellate ulcers
and pseudopolyps in the sigmoid colon, and thickening of the rectal
wall. In the months prior to admission, she had worsening perineal
and abdominal symptoms despite treatment with Asacol, Remicade
(5 mg/kg), prednisone (starting at 40 mg/day and tapered), and
prolonged metronidazole. On presentation to the pediatric colon
and rectal surgery clinic she was afebrile with normal vital signs.
Her abdomen was soft and non-tender. Examination of the peri-
neum revealed multiple draining ﬁstulae and ﬂuctuant abscesses
with surrounding induration and erythema. Several irregular, wide,
ulcerating ﬁssures and swollen skin tags were seen on the peri-
neum and in the anal canal. She was very tender on palpation.
She was promptly admitted, intravenous antibiotics (piperacillin/
tazobactam e Zosyn and metronidazole) were started, and she was
taken to the operating room.
Examination under anesthesia and proctoscopy with minimal
insufﬂation revealed severe ulcerative and stricturing anorectal
disease from the anal verge up to 10 cm. There was extensive
destruction of the anterior sphincter complex along the path of a
rectovaginal ﬁstula and a ﬁstula to a left labial abscess. A posterior
anal canal opening through a deep ulcer led to several ﬁstula tracts,
a postanal cavity and an ascending cavity above the coccyx. The
abscesses were incised, drained and unroofed. A silastic seton was
placed through the rectovaginal ﬁstula. She was continued one.
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Because of the severity of her perineal disease, she was scheduled
to return to the OR on postoperative day (POD) 2 for examination
and further debridement.
Despite initially feeling much better, she developed a fever to
40 C and became tachycardic to the 140’s from a baseline in the
70’s early on POD 2. Sepsis due to further perineal infection was
suspected. Erect CXR showed no evidence of peritoneal free air. She
was taken to the OR urgently. Examination under anesthesia
revealed clean perineal wounds and no evidence of undrained
cavities. However, copious mucous discharge was pouring out of
the rectum. Further examination revealed a distended ﬁrm
abdomen. An on-table abdominal X-ray showed colonic dilatation
but no evidence of free air (Fig. 1A). An intra-abdominal source of
acute inﬂammation and sepsis was suspected. While the patient
was still under anesthesia, the situation was discussed with her
mother, and laparotomy was recommended. Unfortunately, her
mother refused and insisted on additional objective information.
The patient was awoken from anesthesia. An urgent computed
tomography (CT) scan demonstrated substantial free intra-
abdominal air, colonic distention from the cecum to the rectum, and
inﬂammatory changes in the terminal ileum, distal descending
colon, sigmoid, and rectum (Fig. 1B). During this time she was
aggressively resuscitated and supportively managed, however she
remained tachycardic and febrile and developed signiﬁcant
abdominal distention and pain. The white blood cell count rose
from 7.7 to 17.7, the C-reactive protein (CRP) increased from 32 to
242, the hematocrit dropped from 38 to 29, and the albumin
decreased from 3.7 to 3.4.
Given these ﬁndings, we obtained consent to proceed with
laparotomy. This revealed a necrotic perforation in the proximal
transverse colon with minimal fecal soilage but a large amount of
free air. There was severe diffuse Crohn’s colitis of the entire colon
with marked thickening and narrowing of the mid to proximal
sigmoid and dilation of the rest of the colon. There was active
disease involving the last 10 cm of the terminal ileum. A total
abdominal colectomy was performed along with resection of the
diseased terminal ileum and end ileostomy with Hartmann’s
closure of the rectum. The rectal stump was buried in the subcu-
taneous tissue at the lower end of the midline incision.
The opened specimen showed ﬁndings consistent with Crohn’s
colitis including ileitis and multiple large mucosal ulcers in the
ascending colon and hepatic ﬂexure. There was relatively littleFig. 1. A) Intra-operative supine abdominal X-ray revealing distended loops of bowel but no
free air.gross disease in the transverse colon, but there were severe linear
“rake” ulcers, edema and thickening of the descending and sigmoid
colon (Fig. 2A). The necrotic perforation was through one of the
deep ulcers at the hepatic ﬂexure (Fig. 2B). Pathologic examination
showed transmural chronic and acute inﬂammation and necrotic
ulcers consistent with Crohn’s disease. No discrete granulomas
were seen.
Postoperatively, she progressed well. Her white blood cell count
and CRP trended down, and she completed a course of ciproﬂoxacin
and metronidazole. She was discharged on POD 10. After several
months of recovery, she adapted to her ileostomy and returned to
school full-time. She is maintained on adalimumab and feels better
than she has in many years.
A literature search was performed for human studies from 1950
to 2011 on MEDLINE (NLM, National Library of Medicine, Bethesda,
MD; 1950e2011). The following terms were searched using the
MeSH term and all possible text combinations: acute colitis, toxic
colitis, toxic dilatation, toxic megacolon, and Crohn’s colitis, ulcer-
ative colitis, pediatrics, children, inﬂammatory bowel disease.
Further articles were found through detailed reference review.
2. Discussion
Toxic colitis is a life-threatening condition that is most
commonly seen in patients with inﬂammatory bowel disease. It was
ﬁrst described by Marshak in 1950 as a complication of ulcerative
colitis [3]. For over ﬁfteen years it was thought to be speciﬁc to UC,
until Schachter published the ﬁrst case report in 1967 of toxic colitis
in a patient with Crohn’s disease [4]. The incidence of toxic colitis in
adults is 1e8% in those presenting to a hospital with Crohn’s dis-
ease, and 2e21% in those presenting with ulcerative colitis [5e7]. A
large retrospective population-based study of children in France
found that the incidence of Crohn’s disease has been increasing
over the last 30 years, with a high rate of extensive, complicated
pediatric Crohn’s disease resulting in a cumulative probability of
surgery in 34% of patients within 5 years of diagnosis [8]. However,
only one study reported toxic colitis in pediatric Crohn’s, and this
was in two patients who had been diagnosed with ulcerative colitis
at the time, only developing clear evidence of Crohn’s disease years
later [9,10].
Prompt recognition of toxic colitis is crucial because the process
may lead to bowel perforation, peritonitis and death if not treated
rapidly. The incidence of perforation of toxic colitis in a combinedevidence of free air. B) CT abdomenwith intravenous contrast showing dilated colon and
Fig. 2. A) Subtotal colectomy specimen, gross showing terminal ileal disease, multiple discrete, deep apthous ulcers in the right colon, and long, serpiginous rake ulcers in the left
colon with skip areas. B) Detail of the ascending colon-hepatic ﬂexure ulcers and the perforation (arrows).
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(17e46%) [5,11]. This is important as perforation has been shown to
be themost signiﬁcant predictor of outcome, with mortality as high
as 44% vs. 2% without perforation [6]. A further predictor of poor
outcome is delay in surgery. Fortunately, in our patient, the con-
dition was promptly recognized and deﬁnitively managed with
colectomy, without signiﬁcant delay.
Toxic colitis occurs when the mucosal barrier and immune
system are compromised, allowing bacteria to translocate through
the walls of the colon and produce systemic symptoms of sepsis
[12]. The colonic dilatation is thought to be mediated by both the
inhibitory effect of nitric oxide and the inﬂammation-mediated
destruction of myenteric and Auerbach plexuses, reducing colonic
muscle tone [13,14]. Although initially described as ‘toxic mega-
colon,’ it is clear that marked dilation of the colon only occurs in a
subset of these patients, and is not necessary for the process to
progress to sepsis or perforation. Therefore, it is very important to
identify the problem based on clinical and laboratory ﬁndings and
not on the presence or absence of colonic dilation.
Attempts have been made to standardize the diagnosis of toxic
colitis and thereby improve early recognition. In 1969, Jalan pro-
posed the following criteria for adults, notable for the inclusion of
colonic dilation [15]. These included 1) radiographic evidence of
colonic distention, and 2) at least three subjective criteria which
could include fever >38 C, heart rate >120 beats/min (bpm),
neutrophilic leukocytosis>10,500/mm3, and anemia, and 3) at least
one factor to include dehydration, altered mental status, electrolyte
disturbance, or hypotension [9]. Mid-transverse colon diameter
>5.5 cm on abdominal X-ray was also thought to be predictive [16].
In 2009, the Cleveland Clinic Criteria were proposed. This was a
much simpler system and did not rely on colonic dilation as a factor.
The diagnosis could be made by the presence of any three of the
following in the appropriate setting: 1) temperature >38 C, 2)
heart rate >100 bpm, 3) hemoglobin<10 g/dL, 4) white blood cell
count >10,500/mm3, and 5) albumin <3 g/dL [17]. Of note, given
the absence of colonic dilatation, our patient would have been
missed per the Jalan criteria but would have qualiﬁed per Cleveland
clinic criteria for toxic colitis (4/5 positive). Unfortunately, many of
these criteria cannot be directly applied in children because of
differences in normal ranges and because of a lack of validation in
the pediatric population.
There is a relatively small volume of literature addressing diag-
nosis of toxic colitis in pediatric IBD, andmost refers to patientswith
ulcerative colitis [18e20]. A retrospective caseecontrol trial of ten
children with toxic colitis in the setting of ulcerative colitis showed
that fever, tachycardia, dehydration, and electrolyte abnormalities
were common, but that altered consciousness andhypotensionwere
not [9]. Signiﬁcant radiologic ﬁndings on abdominal X-rays includedtransverse colon lumen diameter 56 mm, aireﬂuid levels, intesti-
nal thickening, and abnormal colonic haustra. Recent consensus
guidelines on acute severe ulcerative colitis in children suggested
the following pediatric criteria for toxic colitis: 1) radiographic evi-
dence of transverse colon diameter >56 mm (>40 mm for those
<10 yrs old) plus 2) anyevidence of systemic toxicity, including fever
>38 C, heart rate >2 standard deviations above the mean for age,
dehydration, electrolyte disturbances, altered consciousness, hypo-
tension or shock [21]. Unfortunately, these criteria again include
colonic diameter. Despite evidence of systemic toxicity, our 10 year
old child with a 42 mm transverse colon diameter would not have
been classiﬁed as having toxic colitis under these criteria. Use of
colonic dilatation alone to guide diagnosis and management in this
case would have been an error.
This report is the ﬁrst to describe an acute severe Crohn’s
exacerbation resulting in toxic colitis and perforation in a child. This
patient had known Crohn’s colitis that was stable on her immu-
nosuppressive regimen and was only being treated for perianal
disease. She developed acute abdominal symptoms soon after a
perineal procedure and rapidly progressed to toxic colitis and
perforation. Fortunately, she was in the hospital at the time and
underwent prompt emergent colectomy. Because of the large adult
and pediatric experience at our institution, the problem was iden-
tiﬁed and treated expeditiously, resulting in a good outcome. This
case illustrates the importance of timely and appropriate manage-
ment of these cases, as well as the understanding that colonic
dilatation is not necessary for the diagnosis of toxic colitis. We
believe that the incidence of this problem will increase along with
the increasing incidence of Crohn’s disease in children. It is likely
that this complication is under reported in the pediatric population
accounting for the paucity of reports in the literature.3. Conclusion
Since its ﬁrst description in 1950, the clinical syndrome of toxic
colitis has become associated with an increasing number of in-
ﬂammatory and infective colitides. To our knowledge, this is the
ﬁrst case report describing toxic colitis in a child with the diagnosis
of Crohn’s disease. As the inﬂammatory bowel disease phenotype is
commonly more severe in the pediatric population, awareness that
toxic colitis can manifest in pediatric Crohn’s, does not absolutely
present with colonic dilatation, and how its presentation may differ
from adults, is essential to preventing delays in diagnosis and
treatment of this condition.
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